Serum 25(OH)D and Type 2 Diabetes Mellitus

被引:0
作者
Shanthi, Balasubramanian [1 ]
Revathy, Carnagarin [1 ]
Devi, Arcot Jagdeeshwaran Manjula [2 ]
Parameshwari, Parthasarathy Jaganathan [3 ]
Stephen, Thatiparthi [3 ]
机构
[1] Balaji Med Coll & Hosp, Dept Biochem, C-C Works Rd Chrompet, Madras 600044, Tamil Nadu, India
[2] Sree Balaji Med Coll & Hosp, Dept Biochem, Madras 600044, Tamil Nadu, India
[3] Sree Balaji Med Coll & Hosp, Dept Community Med, Madras 600044, Tamil Nadu, India
关键词
Vitamin D; HbA1c; type; 2; diabetes;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: 25(OH) Vitamin D is the circulating form of vitamin D which is measurable in the blood. Vitamin D insufficiency has been defined as serum 25-hydroxyvitamin D (25(OH) D) levels below 30 ng/mL and it is common among patients with type 2 diabetes mellitus (DM). Aim and Objectives: Our aim was to investigate the clinically meaningful associations which implicated low serum levels of 25(OH) D with impaired diabetic control in DM type 2. Methods: The serum 25( OH) and the HbA1c levels were determined in 50 patients with DM type 2, along with their FBS, PPBS and HBA1c and other parameters which were required to assess the diabetic control were also measured. Results: The results of our study revealed a trend towards an inverse vitamin D-FBS (Pearson correlation, r = - 0.090) and inverse vitamin D-PPBS (Pearson correlation, r = -0.095) association. The lower serum 25(OH) D levels were associated with the higher HbA1c levels (Pearson correlation, r = -0.173). This was a borderline association which may have probably occurred due to the small sample size. Conclusion: The association between the low serum 25(OH) D levels and elevated HBA1c in the study population may be inscribed into a wider context, portraying vitamin D insufficiency as a poor prognostic factor, which may play a vital role in impairing the glycaemic control.
引用
收藏
页码:774 / 776
页数:3
相关论文
共 23 条
[1]  
Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4
[2]   SERUM-PROTEIN BINDING OF 1,25-DIHYDROXYVITAMIN-D - A REEVALUATION BY DIRECT MEASUREMENT OF FREE METABOLITE LEVELS [J].
BIKLE, DD ;
SIITERI, PK ;
RYZEN, E ;
HADDAD, JG ;
GEE, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (05) :969-975
[3]   Expression of 25-hydroxyvitamin D3-1α-hydroxylase in pancreatic islets [J].
Bland, R ;
Markovic, D ;
Hills, CE ;
Hughes, SV ;
Chan, SLF ;
Squires, PE ;
Hewison, M .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 89-90 (1-5) :121-125
[4]  
BOURLON PM, 1999, J ENDOCRINOL, V160, P87, DOI DOI 10.1677/JOE.0.1600087
[5]   Polymorphism of the tumor necrosis factor-α receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients [J].
Fernández-Real, JM ;
Vendrell, J ;
Ricart, W ;
Broch, M ;
Gutiérrez, C ;
Casamitjana, R ;
Oriola, J ;
Richart, C .
DIABETES CARE, 2000, 23 (06) :831-837
[6]   Calcium paradox disease: Calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload [J].
Fujita, T ;
Palmieri, GMA .
JOURNAL OF BONE AND MINERAL METABOLISM, 2000, 18 (03) :109-125
[7]   How should HbA1c measurements be reported? [J].
Gorus, F ;
Mathieu, C ;
Gerlo, E .
DIABETOLOGIA, 2006, 49 (01) :7-10
[8]   The common -675 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is strongly associated with obesity [J].
Hoffstedt, J ;
Andersson, LL ;
Persson, L ;
Isaksson, B ;
Arner, P .
DIABETOLOGIA, 2002, 45 (04) :584-587
[9]   Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes [J].
Illig, T ;
Bongardt, F ;
Schöpfer, A ;
Müller-Scholze, S ;
Rathmann, W ;
Koenig, W ;
Thorand, B ;
Vollmert, C ;
Holle, R ;
Kolb, H ;
Herder, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (10) :5053-5058
[10]   DEMONSTRATION OF A HIGH-AFFINITY RECEPTOR FOR 1,25-DIHYDROXYVITAMIN-D3 IN RAT PANCREAS [J].
ISHIDA, H ;
NORMAN, AW .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1988, 60 (2-3) :109-117